Variant · Snv
MATR3 NM_018834.6(MATR3):c.1602+6A>G
CI-VAR-00047214Explore in graph →NM_018834.6:c.1602+6A>GClinVar 263208 rs80036770
Curated evidence
Evidence by cancer (0 items)
Grouped by cancer context first, then therapy. The same variant can be sensitizing in one cancer and irrelevant in another — contexts are never merged. 50 items per page; a cancer group may continue on the next page.
Data not yet available
No curated evidence item references this variant yet.
ClinVar
Clinical significance (1)
ClinVar interpretations are shown as structured records — significance, review status, star rating, conditions — never flattened into one word.
clinvarProvenance
- Source
- NCBI ClinVar (variant_summary)
- Dataset
- ClinVar variant_summary
- Version
- 2026-09-14
- Retrieved
- Sep 15, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Evidence
- database
- License
- Public domain (US Government work, NCBI/NLM); acknowledgment requested
- Run
- ING-CLINVAR-20260915-000001
| Variation | Clinical significance | Review status | Stars | Conditions | Origin | Submitters | Last evaluated | Source |
|---|---|---|---|---|---|---|---|---|
| 263208 | Benign/Likely benign | criteria provided, multiple submitters, no conflicts | 2 | Amyotrophic lateral sclerosis type 21; Malignant tumor of esophagus; Cervical cancer; Lung cancer; Uveal melanoma; Gastric cancer; Ovarian serous cystadenocarcinoma; Acute myeloid leukemia | germline | 8 | Feb 02, 2026 | clinvar |